Association analysis of the expression level of Nrf2 mRNA in peripheral blood nucleated cells and the severity of chemotherapy-induced myelosuppression
Abstract
Keywords
Full Text:
PDFReferences
National Cancer Prevention and Cure Research Office, The National Cancer Registration Center, The Ministry of health and prevention and Control Bureau compiling the death from cancer report in China——The third National Death retrospective sampling survey[M]. Beijing: People's Medical Publishing House , 2010.
FRIBERG L E, KARLSSON M O. Mechanistic models for myelosuppression[J]. Invest New Drugs, 2003,21(2):183–194.
CANCELAS J A, KOEVOET W L, DE KONING A E,et al. Connexin-43 gap junctions are involved in multiconnexin-expressing stromal support of hemopoietic progenitors and stem cells[J]. Blood,2000, 96(2):498–505.
ITO K, HIRAO A, ARAI F, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells[J]. Nat Med, 2006, 12(4):446−451.
NUMAZAWA S, SUGIHARA K, MIYAKE S, et al. Possible involvement of oxidative stress in 5-fluorouracil-mediated myelosuppression in mice[J]. Basic Clin Pharmacol Toxicol, 2011, 108 (1):40-45.
YU S, KONG A N. Targeting carcinogen metabolism by dietary cancer preventive compounds [J]. Curr Cancer Drug Targets, 2007, 7(5):416-424.
JUNG KA, KWAK M K. The Nrf2 system as a potential target for the development of indirect antioxidants[J]. Molecules, 2010,15(10):7266-7291.
NIH, NCI. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0 (CTCAEv3 )[EB/OL] Bethesda, Maryland 20892, Public Health Service, National Institutes of Health, National Cancer Institute, 2003 [2006 -08-19].http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ docs/ctcaev3.pdf
LYMAN G H, LYMAN C H, AGBOOLA O. Risk models for predicting chemotherapy-induced neutropenia[J]. Oncologist, 2005, 10(6):427-437.
Guo Yan Xia , Yu Cheng Bao , Liu Qiu Ju . Establishment of predictive model for myelosuppression after chemotherapy[J]. Jilin Medical Journal, 2005, (12):1257-1259.
Cai Xun ,Xue Peng , Song Wei Feng , etc . Role of serum concentration monitoring of fluorouracil in further improving chemotherapy efficacy and reducing adverse reactions in advanced gastric cancer [J]. Tumor , 2011, 31(10): 930-036.
HOSSEINIMEHR S J, KARAMI M. Chemoprotective effects of captopril against cyclophosphamideinduced genotoxicity in mouse bone marrow cells[J]. Arch Toxicol, 2005, 79(8): 482–486.
KATO K, TAKAHASHI K, MONZEN S, et al . Relationship between radiosensitivity and Nrf2 target gene expression in human hematopoietic stem cells[J]. Radiat Res, 2010, 174(2):177-184.
FRIEDMAN A D. Transcriptional control of granulocyte and monocyte development[J]. Oncogene, 2007, 26(47):6816–6828.
GORDON S, TAYLOR P R. Monocyte and macrophage heterogeneity[J]. Nat Rev Immunol,2005, 5(12):953–964.
MOTOHASHI H, YAMAMOTO M. Carcinogenesis and transcriptional regulation through Maf recognition elements[J]. Cancer Sci, 2007, 98(2):135-139.
QUE L L, WANG H X, CAO B S, et al. The regulation and functions of transcription factor Nrf2 in cancer chemoprevention and chemoresistance[J]. J Chin Pharm Sci, 2011, 20(1):5-19.
DOI: http://dx.doi.org/10.30564/amor.v4i3.179
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Qingshan Wang, Lingling Li, Yu Chen, Sen Liu, Mingde Yin

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.